Libertyville, IL, United States of America

Andrew O Stewart

This inventor holds 38 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Calcium Channel Blockers. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Abbott Gmbh & Co Kg. Active years: 1989-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew O Stewart. Retrieved from https://idiyas.com/inventor/andrew-o-stewart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 5)

% Patents Active = 65.8

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.4

ph-index = 10

Forward Citations = 527(Granted Patents)

Location History:

Garden Grove, CA (US) (1992)
Wildwood, IL (US) (1992 - 1996)
Libertyville, IL (US) (1989 - 2014)

Company Filing History:

33 out of 4,187

Abbott Laboratories Corporation

4. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2014

Loading Chart...

Areas of Expertise:

Calcium Channel Blockers

Sexual Dysfunction

Acetamides

Benzimidazoles

Lipoxygenase Inhibitors

Anti-Inflammatory Compounds

Prostaglandin Inhibitors

Fused Bicyclic Aromatic Compounds

Oxime Derivatives

Arylalkyl Compounds

Phenylalkyl Carboxylates

Substituted Amines

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8815869 - Lactam acetamides as calcium channel blockers (2014-08-26),

2. 8741899 - (4-chloro-2-fluoro-N-(2-fluorophenyl)-5-[(8aR)-hexahydropyrrolo-[1,2-a]pyrazin-2(1H)-ylcarbonyl]-benzenesulfonamide, and pharmaceutically acceptable salts thereof (2014-06-03),

3. 8691865 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers (2014-04-08),

4. 8404719 - Substituted piperidinylcarbonylbenzenesulfonamides as calcium channel blockers (2013-03-26),

5. 8129417 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers (2012-03-06),

6. 8101614 - Substituted pyrrolo [1,2-a] pyrazines as calcium channel blockers (2012-01-24),

7. 8044069 - Compounds as calcium channel blockers (2011-10-25),

8. 7528134 - Acetamides and benzamides that are useful in treating sexual dysfunction (2009-05-05),

9. 7470691 - Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction (2008-12-30),

10. 7351828 - Benzimidazoles that are useful in treating sexual dysfunction (2008-04-01),

11. 7235661 - Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction (2007-06-26),

12. 7115591 - Prostaglandin endoperoxide H synthase biosynthesis inhibitors (2006-10-03),

13. 7057042 - Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction (2006-06-06),

14. 7022728 - Benzimidazoles that are useful in treating male sexual dysfunction (2006-04-04),

15. 7001895 - Prostaglandin endoperoxide H synthase biosynthesis inhibitors (2006-02-21),

Title: The Innovative Journey of Andrew O Stewart - Pioneering Patent Holder

Introduction:

Andrew O Stewart, a distinguished inventor hailing from Libertyville, IL (US), has left an indelible mark in the realm of patents with an impressive portfolio of 37 groundbreaking inventions.

Latest Patents:

Among his recent patents is the pioneering work on "Lactam Acetamides as Calcium Channel Blockers," which showcases his expertise in developing compounds with formula (I) for treating a range of conditions effectively. Another notable patent is the formulation of "4-Chloro-2-Fluoro-N-(2-Fluorophenyl)-5-[(8aR)-Hexahydropyrrolo-[1,2-a]pyrazin-2 (1H)-ylcarbonyl]-benzenesulfonamide," demonstrating his innovative approach to calcium channel inhibitors.

Career Highlights:

Andrew O Stewart's professional journey has seen him make significant contributions at renowned companies such as Abbott Laboratories Corporation and AbbVie Inc. His innovative spirit and dedication have been instrumental in shaping the landscape of pharmaceutical inventions.

Collaborations:

Throughout his career, Stewart has collaborated closely with esteemed colleagues including the likes of Pramila A Bhatia and Teodozyj Kolasa. These partnerships have fostered a culture of innovation, leading to the development of cutting-edge solutions in the field of medicine.

Conclusion:

In conclusion, Andrew O Stewart stands as a beacon of innovation in the world of patents, with a stellar track record of transformative inventions. His pioneering work continues to inspire future generations of inventors and researchers, driving progress and innovation in the healthcare industry.

Profile summary based on public USPTO records.